The cephalosporins

被引:92
作者
Marshall, WF
Blair, JE
机构
[1] Mayo Clin & Mayo Fdn, Div Infect Dis & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin Scottsdale, Div Infect Dis & Internal Med, Scottsdale, AZ USA
关键词
D O I
10.4065/74.2.187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The cephalosporins are a large group of related beta-lactam antimicrobial agents. Favorable attributes of the cephalosporins include low rates of toxicity, relatively broad spectrum of activity, and ease df administration. Various cephalosporins are effective for treatment of many conditions, including pneumonia, skin and soft tissue infections, bacteremia, and meningitis, Differences among the numerous cephalosporin antimicrobial agents are sometimes subtle; however, an understanding of these differences is essential for optimal use of these agents. As a result of widespread use of cephalosporins, bacterial resistance to these drugs is increasingly common. New, fourth-generation agents (such as cefepime) offer an alternative for the treatment of infections caused by some drug-resistant microorganisms.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 26 条
[1]  
ANNE S, 1995, ANN ALLERG ASTHMA IM, V74, P167
[2]   Cefotaxime - A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections [J].
Brogden, RN ;
Spencer, CM .
DRUGS, 1997, 53 (03) :483-510
[3]   CEPHALOSPORIN-INDUCED RECURRENT ASEPTIC-MENINGITIS [J].
CREEL, GB ;
HURTT, M .
ANNALS OF NEUROLOGY, 1995, 37 (06) :815-817
[4]   CEFEPIME [J].
CUNHA, BA ;
GILL, MV .
MEDICAL CLINICS OF NORTH AMERICA, 1995, 79 (04) :721-732
[5]   SAFETY OF PARENTERAL 3RD-GENERATION CEPHALOSPORINS [J].
FEKETY, FR .
AMERICAN JOURNAL OF MEDICINE, 1990, 88 (4A) :S38-S44
[6]   LORACARBEF - A NEW ORALLY-ADMINISTERED CARBACEPHEM ANTIBIOTIC [J].
FORCE, RW ;
NAHATA, MC .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (03) :321-329
[7]   CEFPODOXIME PROXETIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL [J].
FRAMPTON, JE ;
BROGDEN, RN ;
LANGTRY, HD ;
BUCKLEY, MM .
DRUGS, 1992, 44 (05) :889-917
[8]   TREATMENT OF STREPTOCOCCAL ENDOCARDITIS WITH A SINGLE DAILY DOSE OF CEFTRIAXONE SODIUM FOR 4 WEEKS - EFFICACY AND OUTPATIENT TREATMENT FEASIBILITY [J].
FRANCIOLI, P ;
ETIENNE, J ;
HOIGNE, R ;
THYS, JP ;
GERBER, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (02) :264-267
[9]  
FRANCIOLI PB, 1993, INFECT DIS CLIN N AM, V7, P97
[10]  
GODDARD JK, 1994, PHARMACOTHERAPY, V14, P488